Advances in Integrated Multi-omics Analysis for Drug-Target Identification
Biomolecules · 14.06.2024 · 14 (6) · 692
DOI: 10.3390/biom14060692 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 14.06.2024. Verfasst von Peiling Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China. Hauptthemen laut MEDLINE: Genomics, Drug Discovery, Proteomics. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Zhejiang Province, Nature Scientific Research Foundation for Scholars of Hangzhou No…, National Natural Science Foundation of China, Nature Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
As an essential component of modern drug discovery, the role of drug-target identification is growing increasingly prominent. Additionally, single-omics technologies have been widely utilized in the process of discovering drug targets. However, it is difficult for any single-omics level to clearly expound the causal connection between drugs and how they give rise to the emergence of complex phenotypes. With the progress of large-scale sequencing and the development of high-throughput technologies, the tendency in drug-target identification has shifted towards integrated multi-omics techniques, gradually replacing traditional single-omics techniques. Herein, this review centers on the recent advancements in the domain of integrated multi-omics techniques for target identification, highlights the common multi-omics analysis strategies, briefly summarizes the selection of multi-omics analysis tools, and explores the challenges of existing multi-omics analyses, as well as the applications of multi-omics technology in drug-target identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
- Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of…
ORCID-Profile: Yingqian Zhang
Förderung
- National Natural Science Foundation of China, Nature Science Foundation of Zhejiang Province, Nature Scientific Research Foundation for Scholars of Hangzhou No…
- National Natural Science Foundation of China
- Nature Science Foundation of Zhejiang Province
- Nature Scientific Research Foundation for Scholars of Hangzhou Normal University
Zitieren
APA
Du, P., Fan, R., Zhang, N., Wu, C., & Zhang, Y. (2024). Advances in Integrated Multi-omics Analysis for Drug-Target Identification. Biomolecules, 14(6), 692. https://doi.org/10.3390/biom14060692
Vancouver
Du P, Fan R, Zhang N, Wu C, Zhang Y. Advances in Integrated Multi-omics Analysis for Drug-Target Identification. Biomolecules. 2024;14(6):692. doi:10.3390/biom14060692
BibTeX
@article{Du2024,
author = {Du, Peiling and Fan, Rui and Zhang, Nana and Wu, Chenyuan and Zhang, Yingqian},
title = {Advances in Integrated Multi-omics Analysis for Drug-Target Identification},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {6},
pages = {692},
doi = {10.3390/biom14060692}
}
EUVIMED